Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 1/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | SERPINE1 | P05121 | 8/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | KCNK2 | O95069 | 1/20 | 0.44 |
| ▸ | KCNK10 | P57789 | 1/20 | 0.44 |
| ▸ | PLK1 | P53350 | 2/20 | 0.43 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.43 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.43 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.43 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.43 |
| ▸ | F10 | P00742 | 1/20 | 0.43 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.43 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6833894 | 0.89 | ALB (0.77) | ALBKDM4EHTTKCNK2KCNK10 | |
| SCHEMBL6821338 | 0.88 | ALB (0.60) | ALBKDM4ESERPINE1KCNK2KCNK10 | |
| SCHEMBL6830537 | 0.87 | ALB (1.00) | ALBKDM4EHTTPLK1AKR1C2 | |
| SCHEMBL6835722 | 0.85 | PLK1 (0.57) | ALBKDM4ESERPINE1HTTTP53 | |
| SCHEMBL6818627 | 0.78 | ALB (0.59) | ALBKDM4EKCNK2KCNK10PLK1 | |
| SCHEMBL6819161 | 0.76 | ALB (0.79) | ALBPLK1AKR1C2AKR1C1F10 | |
| SCHEMBL6834113 | 0.74 | KDM4E (0.46) | ALBKDM4ESERPINE1KCNK2KCNK10 | |
| SCHEMBL6813815 | 0.74 | PLK1 (0.57) | ALBKDM4EHTTKCNK2KCNK10 | |
| SCHEMBL6818760 | 0.73 | PLK1 (0.49) | ALBKDM4ESERPINE1KCNK2KCNK10 | |
| SCHEMBL6830644 | 0.73 | ALB (0.77) | ALBKDM4EHTTPLK1AKR1C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | GABRD, GABBR1, GABRA1 | ALB 1417/4885KDM4E 1240/4885SERPINE1 1860/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.